Ocuflox (ofloxacin opthalmic solution) 0.3%

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved May 1996

Specific Treatments:

corneal ulcers

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Ocuflox has been approved for the treatment of corneal ulcers. The approval also supports the broader use of Ocuflox, which is already indicated for the treatment of bacterial conjunctivitis. Ocuflox is part of a class of anti-bacterial agents called fluoroquinolones that exhibit a broad spectrum of activity, low resistance, and favorable side-effects profile.